NDAINTRAVENOUSSOLUTION
Approved
Apr 2015
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
MOXIFLOXACIN HYDROCHLORIDE (moxifloxacin hydrochloride) by Fresenius Kabi is [see microbiology ()]. First approved in 2015.
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Moxifloxacin HCl is a fluoroquinolone antibiotic administered intravenously as a solution for bacterial infections. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and transcription. This broad-spectrum agent is used across respiratory, skin, and intra-abdominal infection indications.
Peak
Product is at peak commercial maturity with moderate competitive pressure (30%), suggesting stable team size and focus on market defense rather than aggressive expansion.
Mechanism of Action
[see Microbiology ()].
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery
Started Jan 2024
102 enrolled
Post Operative Endophthalmitis
Career Relevance
Working on moxifloxacin HCl positions you in a stable, mature antibiotic portfolio with focus on commercial excellence and operational efficiency rather than innovation. Career growth depends on competitive intelligence, payer strategy, and supply-chain optimization in a crowded generic-pressured market.
Brand Manager
Worked on MOXIFLOXACIN HYDROCHLORIDE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.